STAT Plus IBM halting sales of Watson AI tool for drug discovery amid sluggish growth

STAT Plus: IBM halting sales of Watson AI tool for drug discovery amid sluggish growth

04:30 EDT 18 Apr 2019 | STAT

IBM is halting development and sales of its Watson artificial intelligence software to help pharmaceutical companies discover new treatments.